ARTICLE SUMMARY:
SurgiMab’s fluorescence-labeled antibodies will enable surgeons to find otherwise undetectable malignancies, allowing them to remove cancers they might have previously missed, and spare healthy tissue. By Deborah Erickson.
“There is more here than meets the eye.” Sadly, this common phrase often proves all too true when it comes to cancer. Surgeons do their best to remove cancerous tissue, even allowing some extra margin when possible to be sure they get it all. But the reality is, they can’t take what they can’t see.
